CSIMarket
 


Applied Molecular Transport Inc   (AMTI)
Other Ticker:  
 

Cumulative Applied Molecular Transport Inc 's Leverage Ratio for Trailing Twelve Months Period

AMTI's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

AMTI Leverage Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Growth -79.28 % -78.88 % -71.73 % -62.81 % -58.19 %
Y / Y Total Liabilities Growth -94.76 % -91.29 % -12.43 % -7.62 % 136.56 %
Leverage Ratio for Trailing Twelve Months Period 0.75 0.74 0.69 0.54 0.43
Total Ranking # 1393 # 1432 # 1442 # 1374 # 1121
Seq. Equity Growth -21.34 % -42.88 % -40.59 % -22.4 % -19.8 %
Seq. Total Liabilities Growth -43.86 % -90.85 % 1.17 % 0.86 % -6.66 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Despite debt repayement of -43.86% in III. Quarter, Leverage Ratio for Trailing Twelve Months Period improved to 0.75, above Applied Molecular Transport Inc 's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 108 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Applied Molecular Transport Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are AMTI's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 109
Sector # 158
S&P 500 # 285


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.76 0.35 0.07
(Sep 30 2023)   (Mar 31 2021)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Leverage Ratio for Trailing Twelve Months Period
Jazz Pharmaceuticals Plc  2.06 
Bristol myers Squibb Company  2.04 
Abeona Therapeutics Inc   2.03 
Zoetis Inc   2.01 
Blueprint Medicines Corporation  2.01 
Vaccinex Inc   1.99 
Maravai Lifesciences Holdings Inc   1.97 
G1 Therapeutics Inc   1.95 
Plx Pharma Inc   1.91 
Proqr Therapeutics N v   1.90 
Societal Cdmo Inc   1.85 
Nls Pharmaceutics Ltd   1.83 
Vbi Vaccines Inc  1.82 
Corbus Pharmaceuticals Holdings Inc   1.82 
Durect Corp  1.78 
Petros Pharmaceuticals inc   1.77 
Mei Pharma Inc   1.76 
Mirum Pharmaceuticals Inc   1.75 
Rvl Pharmaceuticals Plc  1.71 
Kineta Inc   1.70 
Marinus Pharmaceuticals Inc   1.69 
Summit Therapeutics Inc   1.66 
Biofrontera Inc   1.66 
Tempest Therapeutics Inc   1.66 
Orgenesis Inc   1.60 
Arcutis Biotherapeutics Inc   1.59 
Grifols Sa  1.55 
Timber Pharmaceuticals Inc   1.54 
Pieris Pharmaceuticals Inc   1.54 
Tg Therapeutics Inc   1.53 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com